Date:12/16/2009

evenues 87,589 90,352 345,197 352,362 ------ ------ ------- ------- Cost of revenues: Cost of product sales 45,048 49,838 182,385 192,848 Cost of contract manufacturing and services 4,151 3,174 14,252 14,000 ----- ----- ------ ------ Total cost of revenues 49,199 53,012 196,637 206,848 ------ ------ ------- ------- Gross margin 38,390 37,340 148,560 145,514 ------ ------ ------- ------- Operating expenses: Research and development 6,938 7,145 27,448 26,223 Selling, general and administrative 12,616 13,412 50,027 54,181 Amortization of intangible assets 1,479 1,947 6,389 7,422 Other operating expenses 124 914 1,080 1,504 --- --- ----- ----- Total operating expenses 21,157 23,418 84,944 89,330 ------ ------ ------ ------ Income from operations 17,233 13,922 63,616 56,184 Interest income (expense) and other, net 1 274 428 1,137 --- --- --- ----- Income before income tax provision 17,234 14,196 64,044 57,321 Income tax provision 6,195 3,732 23,454 19,654 ----- ----- ------ ------ Net income $11,039 $10,464 $40,590 $37,667
'/>"/>

SOURCE Martek Biosciences Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related biology technology :

1. Martek Signs Sole-Source Supply Agreement with Fonterra
2. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
3. Martek Announces Addition to Its Board of Directors
4. Martek to Present at Two Upcoming Investor Conferences
5. Martek Announces Settlement of Patent Dispute with Capsugel France
6. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
7. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
8. Martek to Announce Third Quarter 2009 Results
9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
10. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
11. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels